Physician profile
Michael Mcgehee
NPI 1932714961
$3,917.46
in general payments reported to CMS, 2019-2025
15 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $558 · 2022: $1,303 · 2023: $1,393 · 2024: $294 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,056.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $1,135.13 | 2021-2024 | Ingrezza |
| Abbvie INC. | $1,091.23 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $411.75 | 2021-2025 | Abilify Maintena, Rexulti, Abilify Asimtufii |
| Janssen Pharmaceuticals, INC | $267.59 | 2022-2024 | Invega Sustenna, Invega Trinza, Invega |
| Alkermes, INC. | $264.35 | 2021-2025 | Lybalvi, Aristada, Aristada Initio |
| Axsome Therapeutics, INC. | $133.47 | 2023-2025 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $131.32 | 2021 | |
| Indivior INC. | $109.46 | 2023-2025 | Sublocade, Perseris |
| Jazz Pharmaceuticals INC. | $102.54 | 2021 | |
| Merck Sharp & Dohme LLC | $77.13 | 2023 | Verquvo |
| Vanda Pharmaceuticals INC. | $70.24 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $68.26 | 2023-2025 | Uzedy, Austedo Xr |
| Braeburn INC. | $21.95 | 2025 | Brixadi |
| Lundbeck LLC | $20.79 | 2023 | Rexulti |
| Sun Pharmaceutical Industries INC. | $12.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcgehee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.